JP2013506845A5 - - Google Patents

Download PDF

Info

Publication number
JP2013506845A5
JP2013506845A5 JP2012532359A JP2012532359A JP2013506845A5 JP 2013506845 A5 JP2013506845 A5 JP 2013506845A5 JP 2012532359 A JP2012532359 A JP 2012532359A JP 2012532359 A JP2012532359 A JP 2012532359A JP 2013506845 A5 JP2013506845 A5 JP 2013506845A5
Authority
JP
Japan
Prior art keywords
patient
amount
phosphorus
medical treatment
determining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012532359A
Other languages
English (en)
Japanese (ja)
Other versions
JP5894533B2 (ja
JP2013506845A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/051155 external-priority patent/WO2011041697A1/en
Publication of JP2013506845A publication Critical patent/JP2013506845A/ja
Publication of JP2013506845A5 publication Critical patent/JP2013506845A5/ja
Application granted granted Critical
Publication of JP5894533B2 publication Critical patent/JP5894533B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012532359A 2009-10-01 2010-10-01 リン−タンパク質比の計算方法 Expired - Fee Related JP5894533B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27793509P 2009-10-01 2009-10-01
US61/277,935 2009-10-01
PCT/US2010/051155 WO2011041697A1 (en) 2009-10-01 2010-10-01 Method of calculating a phosphorus-protein ratio

Publications (3)

Publication Number Publication Date
JP2013506845A JP2013506845A (ja) 2013-02-28
JP2013506845A5 true JP2013506845A5 (enExample) 2013-10-17
JP5894533B2 JP5894533B2 (ja) 2016-03-30

Family

ID=43037782

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012532359A Expired - Fee Related JP5894533B2 (ja) 2009-10-01 2010-10-01 リン−タンパク質比の計算方法

Country Status (5)

Country Link
US (1) US8822225B2 (enExample)
EP (1) EP2483685B1 (enExample)
JP (1) JP5894533B2 (enExample)
AU (1) AU2010300386B2 (enExample)
WO (1) WO2011041697A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8845570B2 (en) 2010-04-16 2014-09-30 Baxter International Inc. Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis
US9132219B2 (en) 2010-04-16 2015-09-15 Baxter International Inc. Therapy prediction and optimization of serum potassium for renal failure blood therapy, especially home hemodialysis
US12159716B2 (en) 2019-04-04 2024-12-03 Kpn Innovations, Llc. Methods and systems for generating an alimentary instruction set identifying an individual prognostic mitigation plan
US10553316B1 (en) 2019-04-04 2020-02-04 Kpn Innovations, Llc Systems and methods for generating alimentary instruction sets based on vibrant constitutional guidance
US12040090B2 (en) 2019-04-04 2024-07-16 Kpn Innovations, Llc. Systems and methods for generating alimentary instruction sets based on vibrant constitutional guidance
US11322255B2 (en) 2019-04-04 2022-05-03 Kpn Innovations, Llc. Methods and systems for self-fulfillment of an alimentary instruction set based on vibrant constitutional guidance
US11222727B2 (en) 2019-04-04 2022-01-11 Kpn Innovations, Llc Systems and methods for generating alimentary instruction sets based on vibrant constitutional guidance
US11315684B2 (en) 2019-04-04 2022-04-26 Kpn Innovations, Llc. Systems and methods for generating alimentary instruction sets based on vibrant constitutional guidance
US11594316B2 (en) 2020-05-04 2023-02-28 Kpn Innovations, Llc. Methods and systems for nutritional recommendation using artificial intelligence analysis of immune impacts
US11875889B2 (en) 2020-05-29 2024-01-16 Kpn Innovations, Llc. Methods and systems of alimentary provisioning
US12009085B2 (en) 2020-07-27 2024-06-11 Kpn Innovations, Llc. Systems and methods for scheduling alimentary combinations
US11393572B2 (en) 2020-11-03 2022-07-19 Kpn Innovations, Llc. System and method for modifying a nutrition requirement

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2884124B2 (ja) * 1992-01-31 1999-04-19 鈴与株式会社 リン吸着剤
US5753706A (en) * 1996-12-16 1998-05-19 Hsu; Chen Hsing Methods for treating renal failure
US20040193446A1 (en) 2003-03-27 2004-09-30 Mayer Steven Lloyd System and method for managing a patient treatment program including a prescribed drug regimen
JP4633552B2 (ja) * 2005-06-22 2011-02-16 株式会社テクノメディカ 腎臓機能コントロール状態測定方法及び測定システム
EP2013829A4 (en) 2006-05-02 2010-07-07 Proteus Biomedical Inc PERSONALIZED THERAPEUTIC REGIMES FOR A PATIENT

Similar Documents

Publication Publication Date Title
JP2013506845A5 (enExample)
Bahadır et al. Applications of electrochemical immunosensors for early clinical diagnostics
JP2016535644A5 (enExample)
JP5894533B2 (ja) リン−タンパク質比の計算方法
Yalcin et al. Anti-IgE monoclonal antibody (omalizumab) is effective in treating bullous pemphigoid and its effects on soluble CD200
CA2927004C (en) Improved transcutaneous organ function measurement
Koenig et al. Usefulness of whole blood, plasma, peritoneal fluid, and peritoneal fluid supernatant glucose concentrations obtained by a veterinary point-of-care glucometer to identify septic peritonitis in dogs with peritoneal effusion
CN204839444U (zh) 用于测定透析患者的分布容量的装置
Duranton et al. The saga of two centuries of urea: nontoxic toxin or vice versa?
Kloppenburg et al. Anthropometry-based equations overestimate the urea distribution volume in hemodialysis patients
CN107358033A (zh) 用于慢性肾脏病患者饮食蛋白质摄入的评估方法
US20200155748A1 (en) Peritoneal dialysis adequacy meaurements
RU2012102392A (ru) Способы для оценки реакции тофуса в течение снижающего уровень уратов лечения при лечении узелковой подагры
CN102789536A (zh) 肝脏手术治疗风险无创评估模型的建立方法
WO2007136521A3 (en) Measurement of cardiac output and blood volume by non-invasive detection of indicator dilution for hemodialysis
Ekart et al. Blood pressure measurements and left ventricular mass index in hemodialysis patients
Sebastiani Serum biomarkers for the non-invasive diagnosis of liver fibrosis: the importance of being validated
JP6082732B2 (ja) 心不全を病む患者の危険を評価することを支援するための方法
JP2013228229A5 (enExample)
CN105444862A (zh) 一种腹膜透析瘦体重检测装置
Rumyantsev et al. To the question about the prospective for the updates of clinical guidelines for hemodialysis
CN105433902A (zh) 一种腹膜透析瘦体重检测方法
Umimoto et al. Analysis of uremic substances in dialysate by visible ultraviolet spectroscopy
WO2012178030A3 (en) Accurate measurement of glutathione for disease diagnosis and drug metabolite screening
Sun et al. A Novel Mouse Model of Peritoneal Dialysis-Related Encapsulating Peritoneal Sclerosis: SA-PO668